Invention Grant
- Patent Title: Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof
-
Application No.: US16195184Application Date: 2018-11-19
-
Publication No.: US10967051B2Publication Date: 2021-04-06
- Inventor: Miriam Kidron , Ehud Arbit
- Applicant: ORAMED LTD.
- Applicant Address: IL Jerusalem
- Assignee: ORAMED LTD.
- Current Assignee: ORAMED LTD.
- Current Assignee Address: IL Jerusalem
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: WOPCT/IL2014/050007 20130103
- Main IPC: A61K38/28
- IPC: A61K38/28 ; A61K38/55 ; A61K9/48 ; A61K38/26 ; A61K38/56 ; A61K38/57 ; A61K47/60
Abstract:
Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
Public/Granted literature
- US20190209655A1 Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof Public/Granted day:2019-07-11
Information query
IPC分类:
